1. Palladini G, Dispenzieri A, Gertz MA, Kumar S, Wechalekar A, Hawkins
PN, Schönland S, Hegenbart U, Comenzo R, Kastritis E, Dimopoulos MA, Jaccard A, Klersy C, Merlini G. New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes. J Clin Oncol. 2012 Oct 22. [Epub ahead of print].

2. Buss SJ, Emami M, Mereles D, Korosoglou G, Kristen AV, Voss A,
Schellberg D, Zugck C, Galuschky C, Giannitsis E, Hegenbart U, Ho AD, Katus HA, Schonland SO, Hardt SE. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol.
2012 Sep 18;60(12):1067-76.

3. Schönland SO, Dreger P, de Witte T, Hegenbart U. Current status of
hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis. Bone Marrow Transplant. 2012 Jul;47(7):895-905.

4. Schönland SO, Hegenbart U, Bochtler T, Mangatter A, Hansberg M, Ho
AD, Lohse P, Röcken C. Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients.
Blood. 2012 Jan 12;119(2):488-93.

5. Reece DE, Hegenbart U, Sanchorawala V, Merlini G, Palladini G, Bladé
J, Fermand JP, Hassoun H, Heffner L, Vescio RA, Liu K, Enny C, Esseltine DL, van de Velde H, Cakana A, Comenzo RL. Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis:
results of a phase 1/2 study. Blood. 2011 Jul 28;118(4):865-73.

6. Kristen AV, Giannitsis E, Lehrke S, Hegenbart U, Konstandin M,
Lindenmaier D, Merkle C, Hardt S, Schnabel PA, Röcken C, Schonland SO, Ho AD, Dengler TJ, Katus HA.. Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin-T assay. Blood. 2010;116:2455-61.

7. Bochtler T, Hegenbart U, Heiss C, Benner A, Moos M, Seckinger A, Pschowski-Zuck S, Kirn D, Neben K, Bartram CR, Ho AD, Goldschmidt H, Hose D, Jauch A, Schonland SO. Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14). Blood. 2011 Apr 7;117(14):3809-15.

8. Kieninger B, Eriksson M, Kandolf R, Schnabel PA, Schönland S,
Kristen AV, Hegenbart U, Lohse P, Röcken C. Amyloid in endomyocardial biopsies. Virchows Arch. 2010;456:523-32.

9. Stefan O. Schonland, N. Kröger, C. Wolschke, P. Dreger, AD. Ho,
Hegenbart Ute. Donor lymphocyte infusions in amyloid light chain
amyloidosis: Induction of a "graft-versus-plasma cell-dyscrasia effect".
Haematologica 2009;94:439-41.